Improved outcome with aggressive treatment of hyperglycemia: hype or hope?
Diringer
Michael N
MN
D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D006801:Humans; D006943:Hyperglycemia / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007249:Inflammation / Q000209:etiology* / Q000378:metabolism / Q000503:physiopathology; D007362:Intensive Care Units / Q000592:standards; D009102:Multiple Organ Failure / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology; D011115:Polyneuropathies / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology; D020521:Stroke / Q000150:complications* / Q000378:metabolism / Q000503:physiopathology; D013345:Subarachnoid Hemorrhage / Q000150:complications* / Q000378:metabolism / Q000503:physiopathology; D016896:Treatment Outcome
D007004:Hypoglycemic Agents